📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Research and Development of Senti-AI: Tech-enabled precision & predictive respiratory medicine leveraging an innovative wearable medical device

Lead Participant: SENTI TECH LIMITED

Abstract

**Background**: Imagine what the world would be like for the 500 million people globally suffering with long-term respiratory illnesses, if their lungs could tell them exactly what was wrong, how their illness was progressing, and precisely what to do about it? Well, they can: the problem is we've been listening to what the lungs can tell us, for the past 200 years, with two rubber tubes attached to a metal cone.

The stethoscope is blunt.

Respiratory disease affects one-in-five people worldwide. It is the **third leading cause-of-death**, costing the NHS alone £9.1bn/year_._ Across the EU/UK combined, tangible and intangible costs reach **£69bn/year** an**d £240bn/year** respectively.

Providing patient care relies on healthcare professionals trained in auscultation (listening to chest sounds) to diagnose, monitor, and determine treatments. At least **50% of COPD hospitalisations** (Echevarria, 2018), **75% of asthma emergency admissions** (NHS, 2010), and **two-thirds of asthma deaths** (NRAD, 2014) **are preventable with optimised care.** Continuous autonomous home monitoring of chest sounds could save thousands of lives each day and improve quality-of-life for millions.

Current approaches, including the stethoscope, cannot deliver this.

**Innovation**: Senti-Tech will radically address this problem by delivering optimised and personalised respiratory care, through artificial intelligence built onto their patent-pending innovative smart garment, Senti-Wear. By wearing this T-shirt regularly whilst sleeping, Senti-AI will optimise medical treatments giving people back control over their respiratory health and offering them the best possible quality of life. Senti-AI will detect attacks of these diseases and create opportunities for intervening at the earliest possible moment in these attacks -avoiding hospitalisation and improving speed of recovery. Senti-AI will automatically call for help when help is needed.

Senti-AI is the stethoscope unchained.

**Outcomes**: This project will enable Senti-Tech to build, train, and validate an

Artificial Intelligence to monitor the breath and heart sounds captured by Senti-Wear, providing tailored recommendations and advice. Most respiratory illnesses can be treated adequately at home, provided attacks are caught at the right time and appropriate monitoring is initiated.

The Senti-AI intelligent device system will democratise this excellence-in-care, eliminating a large portion of respiratory hospital admissions. This innovation will improve quality-of-life, and reduce avoidable deaths through prompt and personalised treatment: tech-enabled precision and predictive respiratory medicine.

Lead Participant

Project Cost

Grant Offer

SENTI TECH LIMITED £492,859 £ 345,002
 

Participant

MID AND SOUTH ESSEX NHS FOUNDATION TRUST £3,381 £ 3,381

Publications

10 25 50